Saladaga, Baby Girl .

HRN: 28-71-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
AMPICILLIN 250MG (VIAL)
03/19/2026
03/26/2026
IV
140mg
Q12
T/c Neonatal Sepsis
Remove - Pending Acceptance
03/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2026
03/26/2026
IV
45mg
Q24
T/C Neonatal Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: